GlaxoSmithKline

The Billion Dollar COPD Deal: Who Gains The Most?

Genmab: Genentech, Biogen Idec File for Rehearing in Arzerra Case

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Galapagos business update

[Editorial] GAVI injects new life into HPV vaccine rollout

Prestige Slides On Revenue Miss But Vows More Buys

Prestige Brands Holdings Management Discusses Q4 2013 Results - Earnings Call Transcript

Eight Best Warren Buffett Stocks for High-Yield Dividends and Value Investors

Prestige Brands Holdings, Inc. Reports Record Fourth Quarter Revenues Up 15.3% and EPS of $0.37; Fis